Evidence mapPaperPMID 42589418Full record

ReviewInternational journal of molecular sciences2026

Skin Microbiome in Health and Disease: Dysbiosis and the Emerging Role of Biotics in Therapy and Protection.

Anna Łętocha, Małgorzata Miastkowska, Elżbieta Sikora

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anna ŁętochaDepartment of Organic Chemistry and Technology, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Cracow, Poland.
Małgorzata MiastkowskaDepartment of Organic Chemistry and Technology, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Cracow, Poland.ORCID 0000-0002-4590-9184
Elżbieta SikoraDepartment of Organic Chemistry and Technology, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Cracow, Poland.ORCID 0000-0003-4867-965X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The skin functions primarily as a protective physical shield, defending the body against harmful external factors such as invading microorganisms and toxic agents. When this barrier becomes impaired and skin microbiome homeostasis is disturbed, exacerbation of chronic skin diseases may occur, including atopic dermatitis, psoriasis, and acne. This issue became particularly important during the coronavirus pandemic, when it turned out that handwashing and disinfection removed not only impurities and pathogenic microorganisms but also beneficial components of the skin microbiome. This review provides a critical overview of recent advances in understanding the skin microbiome and its influence on skin health, as well as supportive therapies for the treatment of dermatoses. Contemporary therapeutic approaches focus not only on suppressing inflammatory symptoms but also on modulating the skin microbiome as part of a causal treatment strategy, in which prebiotics and probiotics play a significant role. Moreover, probiotics are also considered a valuable component of anti-aging approaches, as they may help counteract the detrimental effects of ultraviolet (UV) radiation on the skin. By reducing oxidative stress, strengthening the epidermal barrier, and exerting immunomodulatory effects, they may complement traditional photoprotection methods. Nevertheless, further research-particularly into their long-term efficacy and safety-is essential to support their broader clinical and consumer application.

Indexed as

DysbiosisSkinSkin DiseasesSkin MicrobiomeAnimalsCOVID-19HumansMicrobiotaPrebioticsProbioticsPrebioticsdysbiosisprebioticsprobioticsskin microbiome

Identifiers

PMID42589418
PMCPMC13466350

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.